Naoko Iino
Directeur/Membre du Conseil chez ONCOLYS BIOPHARMA INC.
Profil
Naoko Iino currently works at Oncolys BioPharma, Inc., as Outside Director from 2023.
Ms. Iino also formerly worked at SymBio Pharmaceuticals Ltd., as Outside Director, tella, Inc., as Director & Manager-Business Strategy from 2009 to 2012, Medical Planet Inc., as Director & Vice President, Medical Creation KK, as President & Director, and Japan Medical Information Research Institute, Inc., as President & Director.
Postes actifs de Naoko Iino
Sociétés | Poste | Début |
---|---|---|
ONCOLYS BIOPHARMA INC. | Directeur/Membre du Conseil | 01/03/2023 |
Anciens postes connus de Naoko Iino
Sociétés | Poste | Fin |
---|---|---|
SYMBIO PHARMACEUTICALS LIMITED | Directeur/Membre du Conseil | - |
Japan Medical Information Research Institute, Inc.
Japan Medical Information Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Japan Medical Information Research Institute, Inc. engages in the collection, analysis, marketing, and consulting of medical information. The company was founded on July 14, 2005 and is headquartered in Tokyo, Japan. | Directeur/Membre du Conseil | - |
Medical Planet Inc.
Medical Planet Inc. Miscellaneous Commercial ServicesCommercial Services Medical Planet Inc. provides human resource services. The private company is based in Tokyo, Japan. and has subsidiaries in Japan. | Directeur/Membre du Conseil | - |
Medical Creation KK | President | - |
TELLA, INC. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
SYMBIO PHARMACEUTICALS LIMITED | Health Technology |
ONCOLYS BIOPHARMA INC. | Health Technology |
Entreprise privées | 4 |
---|---|
tella, Inc.
tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
Medical Planet Inc.
Medical Planet Inc. Miscellaneous Commercial ServicesCommercial Services Medical Planet Inc. provides human resource services. The private company is based in Tokyo, Japan. and has subsidiaries in Japan. | Commercial Services |
Medical Creation KK | |
Japan Medical Information Research Institute, Inc.
Japan Medical Information Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Japan Medical Information Research Institute, Inc. engages in the collection, analysis, marketing, and consulting of medical information. The company was founded on July 14, 2005 and is headquartered in Tokyo, Japan. | Commercial Services |